glp-1 medications side effects temporary or long-term Medications: Separating Fact from Fiction in Diabetes Management | Chad S. posted on the topic Exploring the Side Effects of
Description
2004;53(Suppl 3):S215S219
doi: 10.1152/ajpendo.00409.2011 54 MinokoshiYAlquierTFurukawaNKimYBLeeAXueBet al
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity since the US Food & Drug Administration first approved semaglutide (brand name Ozempic/Wegovy) for weight loss in 2021
European Bioinformatics Institute, European Molecular Biology Laboratory
Ironically, the market which once expected an immediate, pronounced materialization has now become comfortable with the idea that these slower moving changes arent coming at all
Whiting, S., Derbyshire, E
